Mentioned On
Episode Mentions
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Oncolytic virus therapy for melanoma rejected twice by FDA despite community support; regulatory decision criticized”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis